{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:38:23Z","timestamp":1781897903105,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T00:00:00Z","timestamp":1299628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/npp.2011.24","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T14:59:26Z","timestamp":1299682766000},"page":"1397-1411","source":"Crossref","is-referenced-by-count":96,"title":["AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice"],"prefix":"10.1038","volume":"36","author":[{"given":"Jen Q","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh K","family":"Ketterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L","family":"Clore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan R","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Berry-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence F","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B","family":"Holson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael L","family":"Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis L","family":"Biechele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall T","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M","family":"Scolnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey L","family":"Petryshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Haggarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"key":"BFnpp201124_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbr.2004.08.015","volume":"158","author":"R Arban","year":"2005","unstructured":"Arban R, Maraia G, Brackenborough K, Winyard L, Wilson A, Gerrard P et al (2005). Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res 158: 123\u2013132.","journal-title":"Behav Brain Res"},{"key":"BFnpp201124_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20070797","volume":"408","author":"J Bain","year":"2007","unstructured":"Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H et al (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297\u2013315.","journal-title":"Biochem J"},{"key":"BFnpp201124_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","volume":"28","author":"JM Beaulieu","year":"2007","unstructured":"Beaulieu JM, Gainetdinov RR, Caron MG (2007a). The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28: 166\u2013172.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp201124_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","volume":"49","author":"JM Beaulieu","year":"2009","unstructured":"Beaulieu JM, Gainetdinov RR, Caron MG (2009). Akt\/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49: 327\u2013347.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFnpp201124_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","volume":"132","author":"JM Beaulieu","year":"2008","unstructured":"Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V et al (2008). A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132: 125\u2013136.","journal-title":"Cell"},{"key":"BFnpp201124_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","volume":"122","author":"JM Beaulieu","year":"2005","unstructured":"Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005). An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261\u2013273.","journal-title":"Cell"},{"key":"BFnpp201124_CR7","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1073\/pnas.0307921101","volume":"101","author":"JM Beaulieu","year":"2004","unstructured":"Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR et al (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099\u20135104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201124_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","volume":"27","author":"JM Beaulieu","year":"2007","unstructured":"Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR et al (2007b). Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 27: 881\u2013885.","journal-title":"J Neurosci"},{"key":"BFnpp201124_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/341197a0","volume":"341","author":"MJ Berridge","year":"1989","unstructured":"Berridge MJ, Irvine RF (1989). Inositol phosphates and cell signalling. Nature 341: 197\u2013205.","journal-title":"Nature"},{"key":"BFnpp201124_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-59745-249-6_8","volume":"468","author":"TL Biechele","year":"2008","unstructured":"Biechele TL, Moon RT (2008). Assaying beta-catenin\/TCF transcription with beta-catenin\/TCF transcription-based reporter constructs. Methods Mol Bio 468: 99\u2013110.","journal-title":"Methods Mol Bio"},{"key":"BFnpp201124_CR11","doi-asserted-by":"publisher","first-page":"pdb.prot5223","DOI":"10.1101\/pdb.prot5223","volume":"2009","author":"TL Biechele","year":"2009","unstructured":"Biechele TL, Adams AM, Moon RT (2009). Transcription-based reporters of Wnt\/beta catnein signaling. Cold Spring Harb Protoc 2009: pdb.prot5223.","journal-title":"Cold Spring Harb Protoc"},{"key":"BFnpp201124_CR12","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/sj.npp.1301640","volume":"33","author":"U B\u00f6er","year":"2008","unstructured":"B\u00f6er U, Cierny I, Krause D, Heinrich A, Lin H, Mayr G et al (2008). Chronic lithium salt treatment reduces CRE\/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice. Neuropsychopharmacology 33: 2407\u20132415.","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 9","key":"BFnpp201124_CR13","first-page":"35","volume":"61","author":"CL Bowden","year":"2000","unstructured":"Bowden CL (2000). Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychiatry 61 (Suppl 9): 35\u201340.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201124_CR14","doi-asserted-by":"publisher","first-page":"8911","DOI":"10.1523\/JNEUROSCI.22-20-08911.2002","volume":"22","author":"K Brami-Cherrier","year":"2002","unstructured":"Brami-Cherrier K, Valjent E, Garcia M, Pages C, Hipskind RA, Caboche J (2002). Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J Neurosci 22: 8911\u20138921.","journal-title":"J Neurosci"},{"key":"BFnpp201124_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","volume":"2","author":"JF Cade","year":"1949","unstructured":"Cade JF (1949). Lithium salts in the treatment of psychotic excitement. Med J Aust 2: 349\u2013352.","journal-title":"Med J Aust"},{"key":"BFnpp201124_CR16","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1073\/pnas.96.15.8745","volume":"96","author":"E Chalecka-Franaszek","year":"1999","unstructured":"Chalecka-Franaszek E, Chuang DM (1999). Lithium activates the serine\/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 96: 8745\u20138750.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201124_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","volume":"43","author":"P De Sarno","year":"2002","unstructured":"De Sarno P, Li X, Jope RS (2002). Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43: 1158\u20131164.","journal-title":"Neuropharmacology"},{"key":"BFnpp201124_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yebeh.2007.09.023","volume":"12","author":"D Dencker","year":"2008","unstructured":"Dencker D, Dias R, Pedersen ML, Husum H (2008). Effect of the new antiepileptic drug retigabine in a rodent model of mania. Epilepsy Behav 12: 49\u201353.","journal-title":"Epilepsy Behav"},{"key":"BFnpp201124_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36: 131\u2013137.","journal-title":"Nat Genet"},{"key":"BFnpp201124_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nbt1068","volume":"23","author":"MA Fabian","year":"2005","unstructured":"Fabian MA, Biggs III WH, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG et al (2005). A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23: 329\u2013336.","journal-title":"Nat Biotechnol"},{"key":"BFnpp201124_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(10)60570-3","volume":"375","author":"JR Geddes","year":"2010","unstructured":"Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ et al (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 375: 385\u2013395.","journal-title":"Lancet"},{"key":"BFnpp201124_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cellsig.2008.09.011","volume":"21","author":"V Ghisi","year":"2009","unstructured":"Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A (2009). Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cell Signal 21: 87\u201394.","journal-title":"Cell Signal"},{"key":"BFnpp201124_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1017\/S1461145704004535","volume":"7","author":"TD Gould","year":"2004","unstructured":"Gould TD, Einat H, Bhat R, Manji HK (2004). AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7: 387\u2013390.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp201124_CR24","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2174\/1389450110607011399","volume":"7","author":"TD Gould","year":"2006","unstructured":"Gould TD, Picchini AM, Einat H, Manji HK (2006). Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr Drug Targets 7: 1399\u20131409.","journal-title":"Curr Drug Targets"},{"key":"BFnpp201124_CR25","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/sj.npp.1301254","volume":"32","author":"TD Gould","year":"2007","unstructured":"Gould TD, O\u2019Donnell KC, Picchini AM, Manji HK (2007). Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32: 1321\u20131333.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201124_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/dbio.1997.8552","volume":"185","author":"CM Hedgepeth","year":"1997","unstructured":"Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS (1997). Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185: 82\u201391.","journal-title":"Dev Biol"},{"key":"BFnpp201124_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-6606-2-35","volume":"2","author":"O Kaidanovich-Beilin","year":"2009","unstructured":"Kaidanovich-Beilin O, Lipina TV, Takao K, van Eede M, Hattori S, Laliberte C et al (2009). Abnormalities in brain structure and behavior in GSK-3alpha mutant mice. Mol Brain 2: 35.","journal-title":"Mol Brain"},{"key":"BFnpp201124_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neulet.2007.12.005","volume":"432","author":"WY Kim","year":"2008","unstructured":"Kim WY, Kim S, Kim JH (2008). Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity. Neurosci Lett 432: 54\u201357.","journal-title":"Neurosci Lett"},{"key":"BFnpp201124_CR29","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","volume":"93","author":"PS Klein","year":"1996","unstructured":"Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455\u20138459.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201124_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.biopsych.2008.06.003","volume":"64","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Han MH, Mazei-Robison M, Iniguez SD, Ables JL, Vialou V et al (2008). AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry 64: 691\u2013700.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201124_CR31","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1073\/pnas.0604994103","volume":"103","author":"WS Lai","year":"2006","unstructured":"Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P et al (2006). Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci USA 103: 16906\u201316911.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201124_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.encep.2008.12.007","volume":"35","author":"V Le Roy","year":"2009","unstructured":"Le Roy V, Delmas Y, Verdoux H (2009). Chronic renal complications induced by lithium. Encephale 35: 605\u2013610.","journal-title":"Encephale"},{"key":"BFnpp201124_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4088\/JCP.v65n0206","volume":"65","author":"S Leucht","year":"2004","unstructured":"Leucht S, Kissling W, McGrath J (2004). Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 65: 177\u2013186.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201124_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/S1461145709991143","volume":"13","author":"M Mavrikaki","year":"2010","unstructured":"Mavrikaki M, Nomikos GG, Panagis G (2010). Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. Int J Neuropsychopharmacol 13: 541\u2013548.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp201124_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1471-4159.2008.05240.x","volume":"104","author":"JF McGinty","year":"2008","unstructured":"McGinty JF, Shi XD, Schwendt M, Saylor A, Toda S (2008). Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem 104: 1440\u20131449.","journal-title":"J Neurochem"},{"key":"BFnpp201124_CR36","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1523\/JNEUROSCI.4753-03.2004","volume":"24","author":"WT O\u2019Brien","year":"2004","unstructured":"O\u2019Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S et al (2004). Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24: 6791\u20136798.","journal-title":"J Neurosci"},{"key":"BFnpp201124_CR37","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1042\/BST0371133","volume":"37","author":"WT O\u2019Brien","year":"2009","unstructured":"O\u2019Brien WT, Klein PS (2009). Validating GSK3 as an in vivo target of lithium action. Biochem Soc Trans 37: 1133\u20131138.","journal-title":"Biochem Soc Trans"},{"key":"BFnpp201124_CR38","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.neubiorev.2007.04.002","volume":"31","author":"KC O\u2019Donnell","year":"2007","unstructured":"O\u2019Donnell KC, Gould TD (2007). The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neurosci Biobehav Rev 31: 932\u2013962.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp201124_CR39","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","volume":"66","author":"W Perry","year":"2009","unstructured":"Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ et al (2009). A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66: 1072\u20131080.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201124_CR40","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/npp.2010.43","volume":"35","author":"A Polter","year":"2010","unstructured":"Polter A, Beurel E, Yang S, Garner R, Song L, Miller CA et al (2010). Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 Increases sensitivity to mood disturbances. Neuropsychopharmacology 35: 1761\u20131774.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201124_CR41","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.1523\/JNEUROSCI.5216-05.2006","volume":"26","author":"J Prickaerts","year":"2006","unstructured":"Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I et al (2006). Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 26: 9022\u20139029.","journal-title":"J Neurosci"},{"key":"BFnpp201124_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","volume":"52","author":"DB Ring","year":"2003","unstructured":"Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR et al (2003). Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52: 588\u2013595.","journal-title":"Diabetes"},{"key":"BFnpp201124_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1196\/annals.1369.064","volume":"1074","author":"RB Rothman","year":"2006","unstructured":"Rothman RB, Baumann MH (2006). Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann NY Acad Sci 1074: 245\u2013260.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp201124_CR44","first-page":"2200","volume":"118","author":"HY Tan","year":"2008","unstructured":"Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, Honea R et al (2008). Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Invest 118: 2200\u20132208.","journal-title":"J Clin Invest"},{"key":"BFnpp201124_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.biopsych.2007.06.005","volume":"63","author":"DL Thiselton","year":"2008","unstructured":"Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A et al (2008). AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry 63: 449\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201124_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1017\/S1121189X00000439","volume":"18","author":"L Tondo","year":"2009","unstructured":"Tondo L, Baldessarini RJ (2009). Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psychiatry Soc 18: 179\u2013183.","journal-title":"Epidemiol Psychiatry Soc"},{"key":"BFnpp201124_CR47","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1016\/j.bmcl.2005.08.037","volume":"15","author":"N Vasdev","year":"2005","unstructured":"Vasdev N, Garcia A, Stableford WT, Young AB, Meyer JH, Houle S et al (2005). Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N\u2032-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies. Bioorg Med Chem Lett 15: 5270\u20135273.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFnpp201124_CR48","doi-asserted-by":"publisher","first-page":"30419","DOI":"10.1074\/jbc.274.43.30419","volume":"274","author":"H Yuan","year":"1999","unstructured":"Yuan H, Mao J, Li L, Wu D (1999). Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. J Biol Chem 274: 30419\u201330423.","journal-title":"J Biol Chem"},{"key":"BFnpp201124_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bmcl.2007.11.015","volume":"18","author":"Z Zhao","year":"2008","unstructured":"Zhao Z, Robinson RG, Barnett SF, Defeo-Jones D, Jones RE, Hartman GD et al (2008). Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity. Bioorg Med Chem Lett 18: 49\u201353.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFnpp201124_CR50","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","volume":"98","author":"X Zhuang","year":"2001","unstructured":"Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG et al (2001). Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 98: 1982\u20131987.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:25:54Z","timestamp":1684455954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["BFnpp201124"],"URL":"https:\/\/doi.org\/10.1038\/npp.2011.24","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,9]]}}}